Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) had its price target boosted by UBS AG from $2.50 to $7.50 in a report issued on Monday, Stock Ratings Network.com reports. They currently have a neutral rating on the stock. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened at $6.94 in last trading session, and closed at $6.72, trading in the range of $6.64 – $6.98. The stock showed a positive weekly performance of 2.60%.
MannKind Corporation (NASDAQ:MNKD), the $1.66 billion market capped development stage biotech has another research and development cap in its crown as of January 2 this year. This was in the form of a new patent being granted to cover its new target compound “which directly inhibit IRE-1.alpha activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof”. This proprietary compound was developed by seven co inventors and the patent rests with MannKind Corporation (NASDAQ:MNKD). MannKind Corporation (NASDAQ:MNKD) shares closed at $5.47 on last trade day, by losing -2.23%. Stock 52 week range is $2.34 – $8.70. Company’s market capitalization is $1.96 billion.
Galena Biopharma Inc (NASDAQ:GALE) announced the first patient has been enrolled in the Phase 2 trial for GALE-301 (Folate Binding Protein (FBP) vaccine). GALE-301 is a folate receptor alpha-derived, peptide-based cancer immunotherapy administered to HLA-A2 positive patients in combination with granulocyte macrophage-colony stimulating factor (GM-CSF) as an adjuvant treatment to prevent recurrences in high-risk, endometrial and ovarian cancer patients rendered disease-free after completing standard of care therapy. Galena Biopharma Inc (NASDAQ:GALE) stock rose 3.08% and finished the last session at $5.36. The EPS of the stock remained -0.38. Company’s market capitalization is $564.07 billion.
Inovio Pharmaceuticals, Inc. (NYSE MKT:INO) announced today that Dr. J. Joseph Kim, President and CEO, will present a corporate overview of the company at the Biotech Showcase 2014 investor conference in San Francisco, CA. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock opened at $2.55 in last trading session and closed at $2.50. The 52 week range of the stock is $0.49 – $3.03 and the day range was $2.27 – $2.56.